- Approval Id
- 29259e71d93e014c
- Drug Name
- RINALIX TABLET 2.5 mg
- Product Name
- RINALIX TABLET 2.5 mg
- Approval Number
- SIN11664P
- Approval Date
- 2001-09-13
- Registrant
- APEX PHARMA MARKETING PTE. LTD.
- Licence Holder
- APEX PHARMA MARKETING PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- TABLET, FILM COATED
- Dosage
- **Dosage and Administration**
To be administered orally.
_Hypertension:_ 2.5 mg daily, to be taken in the morning. The action of Indapamide is progressive and the reduction in blood pressure may continue and not reach a maximum until several months after the initiation of therapy. A larger dose than 2.5 mg Indapamide is not recommended as there is no appreciable antihypertensive effect but a diuretic effect may become apparent.
- Route Of Administration
- ORAL
- Indication Info
- **Indications**
Rinalix is indicated for the treatment of essential hypertension, alone or in combination with other antihypertensive drugs.
- Contraindications
- **Contraindications**
Anuria, stroke, recent cerebrovascular accident, severe hepatic insufficiency, known hypersensitivity to indapamide or to other sulfonamide-derived drugs.
- Atc Code
- C03BA11
- Atc Item Name
- indapamide
- Pharma Manufacturer Name
- APEX PHARMA MARKETING PTE. LTD.
- Company Detail Path
- /organization/apex-pharma-marketing-pte-ltd
